Panel Discussion | Endovascular Potpourri

Monday, March 9, 2026

4:49 PM - 5:15 PM EST

Location: Jefferson

Moderator(s)

Mohammad M. Ansari, MD

Assistant Professor/ Cath Lab Director
Texas Tech University Health Sciences Center
Lubbock, Texas, United States

Disclosure information not submitted.
Robert M. Bersin, MD, MPH, FSCAI

Medical Director, Endovascular Services
Swedish Heart and Vascular (Emeritus)
Parc de la Baie Orientale, France

Disclosure(s): Nectero, Inc.: Stock-privately held company (Ongoing)
Jihad A. Mustapha, MD FACC FSCAI

Interventional Cardiologist
Lorven Heart & Vascular Institute
Ada , Michigan, United States

Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Discussant(s)

Eric J. Dippel, MD

Interventional Cardiologist
Vascular Institute of the Midwest, PC
Bettendorf, Iowa, United States

Disclosure information not submitted.
James Stephen Jenkins, MD

Section Head, Interventional Cardiology Director, Interventional Cardiology Research
Ochsner Medical Center
New Orleans, Louisiana, United States

Disclosure information not submitted.
Aravinda Nanjundappa, MD, FSCAI

Director of Peripheral Vascular Interventions, Cardiovascular Division
Cleveland Clinic , Main Campus
Pepper pike, Ohio, United States

Disclosure(s): No financial relationships to disclose
Khusrow A. Niazi, MD, FACC, FSCAI, FSVM

Director Peripheral Vascular Interventions
Emory University
Dunwoody, Georgia, United States

Disclosure(s): Cordis, Endovascular Division: Grant/Research Support (Ongoing)
Timir Paul, MD, PhD, FACC, FSCAI

Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
Brentwood, Tennessee, United States

Disclosure(s): No financial relationships to disclose
Thomas Zeller, MD

Director Department Angiology
Universitäts-Herzzentrum Freiburg - Bad Krozingen, University Clinic Freiburg, Germany
Bad Krozingen, Baden-Wurttemberg, Germany

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Robert M. Bersin, MD, MPH, FSCAI: Nectero, Inc.: Stock-privately held company (Ongoing)

Jihad A. Mustapha, MD FACC FSCAI: Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)

S. Jay Mathews, MD: Abiomed: Grant/Research Support (Ongoing); Akura: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gore: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Innova vascular: Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protexa: Stock Options [in privately held companies] (Ongoing); R3: Grant/Research Support (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock Options [in privately held companies] (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Aravinda Nanjundappa, MD, FSCAI: No financial relationships to disclose

Khusrow A. Niazi, MD, FACC, FSCAI, FSVM: Cordis, Endovascular Division: Grant/Research Support (Ongoing)

Timir Paul, MD, PhD, FACC, FSCAI: No financial relationships to disclose